garuda slotvip
2025-01-08   

garuda slotvip NoneNewsom says California could offer electric vehicle rebates if Trump eliminates federal tax creditChristopher Nolan's next film will be a star-studded adaptation of Homer's 'The Odyssey'

NoneInvesting in high-quality growth stocks can help you generate above-average returns over time. Therefore, adding stocks with and high growth potential could be a smart strategy to diversify your portfolio and enhance the overall returns. One of the most appealing aspects of investing in growth stocks is that you don’t need to make a large financial commitment to get started. In fact, with an investment as modest as $500, investors can tap into some of the top growth stocks in Canada. Against this background, here are four with strong growth prospects to buy and hold. ( ) is a top Canadian growth stock with promising potential. The company is strategically positioned to benefit from the surge in artificial intelligence (AI) investments, mainly through its focus on hardware platform solutions for AI/ML systems. As demand for customizable AI silicon grows, Celestica’s advanced networking switches, servers, and storage solutions are set to thrive, especially with rising data centre investments. Beyond AI, the recovery in the Advanced Technology Solutions sector, including aerospace, defence, and industrial markets, will likely accelerate its growth and diversify its revenue streams. Celestica is optimistic about growth in its Industrial and Smart Energy segments in 2025, fueled by increased demand. Overall, with strong prospects across multiple industries, Celestica is poised for sustained growth. Investors seeking high-quality growth stocks could also consider ( ) for its ability to consistently deliver sales and earnings growth at a double-digit rate and generate higher returns over time. Shares of this clothing retailer have risen over 92% this year. The momentum is poised to sustain and on the back of stellar growth in its financials. Notably, Aritzia’s top line has grown at a compound annual growth rate (CAGR) of 19% since fiscal 2016. At the same time, its bottom line increased at a CAGR of 13%. The company will likely continue to deliver stellar financials, thanks to its exclusive mix of fashion brands, wide product offerings, and improvement in the supply chain. Moreover, the company is expanding its store presence in prime retail spaces across Canada and the U.S., which will likely boost revenues, increase brand awareness, grow its customer base, and generate steady growth. Aritzia is also enhancing its omnichannel capabilities, improving operational efficiency, and reducing warehousing costs, which will likely boost its profitability and support its share price. ( ) is an to buy and hold. The financial services company is consistently growing its revenue and earnings at a double-digit rate. Thanks to its stellar financials, goeasy stock has gained substantially in value over the years and outperformed the Canadian benchmark index by a wide margin. Further, it has enhanced its shareholders’ value by increasing dividends for 10 consecutive years and has delivered a higher return on equity (ROE). The subprime lender will benefit from high-quality loan originations and solid credit performance, which will drive its top and bottom lines at a solid double-digit rate. Further, goeasy’s focus on credit adjustments, an improved product mix, and efficiency savings will enhance its margins and profitability. Thanks to its solid financials, goeasy will likely hike its future dividends, while its stock could deliver above-average returns. Moreover, the stock offers significant value near the current price levels and is trading cheap on valuation. ( ) is another compelling growth stock to buy now. This manufacturer of dry-type transformers and power-quality products is witnessing significant demand, led by advancements in AI and vehicle electrification. The company’s exposure to high-growth end markets such as data centers, electric vehicle (EV) charging, and renewable energy, as well as its established presence in industries like utilities, oil and gas, and mining, provide stability. Hammond’s focus on innovation, product expansion, and strategic acquisitions positions it for sustained growth. Further, with improved efficiency and a favourable product mix boosting profitability, Hammond Power is well-placed to enhance shareholder value and sustain its rally.

‘Intrusive and presumptuous’: Fury in Germany after Musk backs far-right party ahead of electionsThe Miami Dolphins are in the middle of climbing themselves back into the AFC playoff picture, rattling off three straight wins to get to 5-6. The Dolphins aren't the only team fighting to stay alive, as the 7-5 Denver Broncos are just ahead, owning the seventh seed. Could the Broncos get help this season from a former Dolphins star? Bleacher Report believes that Denver should sign former All-Pro corner Xavien Howard to aid their playoff push. Xavien Howard remains the top cornerback who doesn't have a team right now. If he's healthy, he would be able to come in and give them a better chance at not missing a beat if Patrick Surtain II or Moss did go down. Howard hasn't played this season, but most recently had a free agent visit with the Cincinnati Bengals a few weeks ago. He was solid last season, with 45 tackles and 12 passes defended in 13 games before a foot injury prematurely ended his campaign. He's 31 years old but proved last year that he can still play. It would create quite the headline for the four-time Pro Bowler to make his return to the league on a playoff team that's currently one seed ahead of his former squad.

Hamilton: Larrañaga chose to go; other coaches pay to stayVirginia Gambale sells $152,512 in Jamf Holding Corp. stockDolphins coach Mike McDaniel says he was surprised by reports of Shaq Barrett's unretirement plan

Two senior federal government sources have confirmed to CTV News that the federal government has sold its stake in Air Canada. The news was first reported by the Globe and Mail. During the COVID-19 pandemic in 2021, the government purchased a six per cent stake in the airline for $500 million as part of a bailout package. Ottawa's rescue deal with Air Canada at the time included a $5.9-billion loan from the government to help support the airline after it lost billions of dollars during the pandemic. As of Thursday afternoon, Air Canada shares closed at $25.28 on the Toronto Stock Exchange, up 23 cents. CTV News reached out to the federal transport minister's office and was referred instead to Deputy Prime Minister and Minister of Finance Chrystia Freeland's office, who has not yet responded. Last week, Transport Minister Anita Anand told CTV News she was "examining the particular legal relationship" with Air Canada in an effort to figure out how to dissuade the airline from bringing in additional carry-on fees. Air Canada has yet to respond to CTV News' request for comment. Ian Lee, associate professor at Carleton University's Sprott School of Business, says the government should have never bought shares in Air Canada in the first place. "Its role is the referee of the hockey game, it should not own the hockey team or tell Sidney Crosby when to shoot the puck," he told CTV News Channel. "The government of Canada provided billions of dollars to many thousands of corporations in Canada and did not take ownership positions in all those other companies." When asked about whether Ottawa selling its shares in Air Canada is in any way connected to the government's spending announcement on Monday, Lee says yes. "There's an awful lot of buzz that they're going to crank up spending yet again. And so, the government needs money. They're rattling the cupboards to see what bits and pieces can be sold off."Charlize Theron Joins Cast of Christopher Nolan’s Next Movie By The cast of ‘s next movie grows larger, with Variety reporting that is set to star in the highly anticipated next project from the director. Theron joins an ensemble cast that already features some of Hollywood’s biggest names in the as-of-now mysterious movie. Previously, it was announced that , , , and would all also star in the upcoming project, which remains shrouded in mystery. Theron is a legend in the world of Hollywood, having risen to superstardom in the 1990s. Throughout her career, she’s starred in several high-profile projects, including The Italian Job, The Devil’s Advocate, Monster, Atomic Blonde, Mad Max: Fury Road, and more. Next up for her will be The Old Guard 2, a sequel to the 2020 action movie that she also starred in. What do we know about Christopher Nolan’s next movie? Early reports suggest that Pattinson, Damon, Holland, and Hathaway will make up “the core leads” of the movie. Lupita Nyong’o and Zendaya, both of whom were , will also have supporting roles in some degree. Nolan’s next, still untitled picture will release in the United States theaters on July 17, 2026, from Universal Pictures. While Nolan hasn’t commented on what his next movie may be about, the latest prominent theory suggests it may involve , one of whom is older and one of whom is younger. It has also been reported that Nolan’s movie will utilize a never-before-used . (Source: ) Anthony Nash has been writing about games and the gaming industry for nearly a decade. When he’s not writing about games, he’s usually playing them. You can find him on Twitter talking about games or sports at @_anthonynash. Share articleBy Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.

31 Products That Were Clearly Invented By People With Very Big Brains

Musk causes uproar for backing Germany's far-right party ahead of key electionsNetanyahu has successful prostate surgeryQatar tribune The US magazine Time has named President-elect Donald Trump its Person of the Year for 2024. “Trump’s political rebirth is unparalleled in American history,” the magazine wrote in its justification on Thursday. “Since he began running for President in 2015, perhaps no single individual has played a larger role in changing the course of politics and history than Trump.” The Time editorial team has been honouring the most influential personalities in world affairs since 1927, and emphasizes that means the person “who, for better or for worse, has most shaped the world and the headlines of the past twelve months.” In many years, the choice is a difficult one, the magazine’s editor-in-chief Sam Jacobs wrote. “In 2024, it was not.” “On the cusp of his second presidency, all of us - from his most fanatical supporters to his most fervent critics - are living in the Age of Trump.” The 78-year-old won the presidential election in early November by a landslide against his Democratic opponent Kamala Harris. After his first - and at the time surprising - election victory in 2016, Time magazine had previously named Trump “Person of the Year”. This time, the award was presented in a special way: Trump rang the bell to open trading on the stock exchange on Wall Street in New York. The US president-elect was accompanied by his wife Melania. (DPA) Copy 13/12/2024 10

It’s almost time for Spotify Wrapped. When can you expect your 2024 recap?Special counsel moves to dismiss election interference and classified documents cases against TrumpKolkata, Nov 26 (PTI) The West Bengal health department has launched a probe into the supplies of allegedly low-quality and locally made catheters at a high price to several government hospitals, posing a risk to the lives of patients undergoing treatment in these facilities, officials said on Tuesday. Such central venous catheters (CVCs) were allegedly supplied to at least five medical colleges and hospitals in the state, defying allocation of international standard-compliant CVCs, they said. The distribution company, which has been accused of supplying these catheters to government hospitals, admitted to the fault but placed the blame on its employees. “We started checking stocks some time back and found these locally made CVCs in my hospital store. These catheters are of low quality as compared to those allocated by the state. We have informed the state health department,” a senior official of the Calcutta Medical College and Hospital told PTI. Low-quality catheters were also found in the stores of other hospitals, which indicates “possible involvement of insiders in the scam”, a health department official said. The low-quality CVCs were supplied by a distributor in Hatibagan area in the northern part of Kolkata for the last three to four months, he said. “Such kinds of local CVCs are priced around Rs 1,500 but the distributor took Rs 4,177 for each device,” the official said. A CVC is a thin and flexible tube that is inserted into a vein to allow for the administration of fluids, blood, and other treatment. It’s also clinically called a central line catheter. “An initial probe revealed that the distribution company Prakash Surgical had supplied the low-quality and locally manufactured catheters to several government hospitals instead of the CVCs of the government-designated international company. “All the units will be tested and a proper investigation is on to find out who benefited from these supplies,” the health department official said. The distribution company blamed its employees for the supplies of inferior quality catheters. “I was sick for a few months. Some employees of the organisation made this mistake. We are taking back all those units that have gone to the hospitals. It’s all about misunderstanding,” an official of the distribution company told PTI. According to another state health department official, a complaint was lodged with the police in this connection. Asked about how many patients were affected by the usage of such low-quality CVCs, the official said, “The probe would also try to find that out”. According to sources in the health department, some of the staff of the hospitals’ equipment receiving department and some local officials of international organisations might be involved in the corruption. PTI SCH BDC This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );

Canada Spooked by Trump's Tariff Threat: 'Devastating'UNLV beats UC Riverside 66-53

Oscar-winning director Christopher Nolan will be taking audiences to mythical Greece with his latest project. Universal Pictures announced this week that Nolan will be directing a cinematic adaptation of " The Odyssey ," an ancient poem believed to be written by Homer between 750 and 650 BCE centering on the character Odysseus' 10-year trek home after the Trojan War. Nolan's forthcoming adaptation is described as "a mythic action epic shot across the world using brand new IMAX film technology," according to the studio's announcement posted to their X page Monday. Zendaya, Tom Holland and Robert Pattinson along with Oscar-winners Matt Damon, Lupita Nyong'o, Anne Hathaway and Charlize Theron are reportedly set to star in the film. Holland recently spoke about signing onto the project, saying on "The Dish" podcast last week that the film hasn't started shooting yet. He added that Nolan only "loosely pitched" it to him when they met to discuss the project, but that he still didn't know all the details. The "Spider-Man" actor also touched on working with his girlfriend Zendaya, joking that "studios love it" when they're on the same project because they only have to pay for "one hotel room." Pattinson, Damon and Hathaway have all previously appeared in Nolan's films, including "Tenet," "Interstellar" and "Oppenheimer." Nolan is also behind epic films including "Inception," "The Dark Knight," "Dunkirk" and his most recent film "Oppenheimer," which scored big at last year's Oscars when it took home the trophy for Best Picture. Nolan won that award as a producer and also took home the Academy Award for Best Director. According to Universal's social media announcement this week, "The Odyssey" will bring Homer's "foundational saga to IMAX film screens for the first time" and will open in theaters on July 17, 2026.Dolphins coach Mike McDaniel says he was surprised by reports of Shaq Barrett's unretirement planA wild first season of the expanded Big 12 is down to what should be a chaotic final weekend. Through all the upsets, unexpected rises and falls, there are nine teams still in the mix to play in the conference championship game. No. 14 Arizona State and No. 17 Iowa State have the best odds, yet a multitude of scenarios could play out — 256 to be exact. There's even the possibility of an eight-team tie. It may take a mathematician to figure out which teams are in the Dec. 7 game in Arlington, Texas — even for the ones who win. Travis Hunter, Colorado. The Buffaloes' two-way star has excelled on both sides of the field, making him one of the favorites to win the Heisman Trophy. Cam Skattebo, Arizona State. The senior running back can do a little of everything, but excels at punishing would-be tacklers. He's one of the nation's leaders in yards after contact and the focal point of the Sun Devils' offense. Shadeur Sanders, Colorado. If it weren't for Hunter, Sanders might be the Heisman favorite. The son of coach Deion Sanders, Shedeur is fifth nationally with 3,488 yards passing and has been a big part of the Buffaloes' turnaround. DJ Giddens, Kansas State. The Wildcats' running back is one of the nation's most versatile players. He is ninth nationally with 1,271 rushing yards and has added 21 receptions for 258 yards. Tetairoa McMillan, Arizona. The Wildcats have struggled this season, but McMillan has not. He is third nationally with 1,251 receiving yards with seven touchdowns on 78 catches. Jacob Rodriguez, Texas Tech. The Red Raiders' junior linebacker leads the Big 12 with 68 tackles, averaging 10.2 per game. He also has four sacks. Brendan Mott, Kansas State. He's a menace to opposing quarterbacks, leading the Big 12 with 8 1/2 sacks. The Big 12 has nine teams already bowl eligible and two more a win away. The winner of the Big 12 championship game will be in the mix for a College Football Playoff spot. Arizona State, Iowa State, No. 19 BYU, Colorado, Kansas State, Baylor, TCU, Texas Tech and West Virginia have already clinched bowl berths. Kansas and Cincinnati can get into the postseason with wins this weekend. Gus Malzahn, UCF. Despite successes in recruiting, the Knights are 10-14 in two seasons since moving to the Big 12. Maybe not enough to get shown the door this year, but another mediocre season could lead UCF to make a change. Kyle Whittingham, Utah. Whittingham was one of the Pac-12's best coaches, leading the Utes to consecutive conference titles. Utah was expected to contend for the Big 12 title its first year in the league, but enters the final weekend 1-7 in conference play, which could push Whittingham toward retirement since it's doubtful he'd be fired. Neal Brown, West Virginia. The Mountaineers' coach was in a precarious spot at the end of last season and West Virginia hasn't lived up to expectations this season. The Mountaineers are eligible to go to a bowl game for the second straight season, but Brown could be on the hot seat even after signing a contract extension before the season. Josiah Trotter, West Virginia. The redshirt freshman is the latest Trotter to have success at the linebacker position, following the footsteps of his father, former Philadelphia Eagles player Jeremiah Trotter, and brother Jeremiah Trotter Jr., a current Eagles linebacker. Sam Leavitt, Arizona State. The Michigan State transfer has been just what the Sun Devils' needed: an agile quarterback who extends plays with his legs and rarely makes bad decisions. Bryson Washington, Baylor. The Bears' running back has rushed for 812 yards — 196 against TCU — and 10 TDs. TCU has the Big 12's highest rated 2025 recruiting class with six four-star players among 26 commitments, according to the 247 Sports composite. Receiver Terry Shelton of Carrollton, Texas, is the highest-rated recruit at 71st nationally. Baylor is next with five five-star players among its 20 commitments, including running back Michael Turner, rated 13th at his position out of North Richland Hills, Texas. Texas Tech is ranked seventh in the Big 12, but has four four-star recruits.

TORONTO (AP) — The Utah Hockey Club said players were forced to walk to their game against the Maple Leafs after their bus got stuck in Toronto traffic Sunday night. The team posted a video on social media of team members walking to Scotiabank Arena, with player Maveric Lamoureux saying the bus was “not moving at all.” Several city streets had been closed during the day for the annual Santa Claus parade. The Maple Leafs earned their fourth consecutive win by defeating Utah 3-2. The viral incident prompted Ontario Premier Doug Ford to call the congestion “embarrassing” and “unacceptable,” highlighting his government’s plan to address the city’s gridlock through bike lane legislation. It wasn’t the first time a Toronto visitor had to ditch their vehicle to make it to an event on time. In June, former One Direction band member Niall Horan had to walk through traffic to get to his concert at Scotiabank Arena. AP NHL: https://apnews.com/hub/nhlRotomolding Market Booms with Rising Demand in Durable Plastic Manufacturing

MEMPHIS, Tenn. , Dec. 12, 2024 /PRNewswire/ -- uLab Systems ® announces an exciting new strategic collaboration with Voxel Dental and LuxCreo, Inc., two other leaders in the orthodontic industry, aimed at advancing the use of direct print aligner technology. All three companies share the vision of transforming the landscape of in-office manufacturing capabilities for orthodontists. Together they will streamline the overall workflow for direct print appliances and further the adoption of this promising technology. "We could not be happier to team up with Voxel and LuxCreo," said Charlie Wen, Co-founder and President of uLab Systems. "This collaboration will enable us to deliver needed advancements in direct print technology workflow, ultimately benefiting our customers and their patients with fast, precise, and cost-effective solutions." Mark Bacino , Vice President of Orthodontic Solutions at Voxel, added, "We're thrilled about the future of direct print aligners with the LuxCreo system. Previously, we were concerned about the lengthy digital workflow, but now, with the integration of uLab's uDesign platform and LuxCreo FastTrack AI, setting up direct print cases is much easier. The reduction in labor time is invaluable, eliminating the need for physically blocking out, thermoforming, cutting, and trimming in-office aligners." Mike Yang , CEO of LuxCreo, commented, "We are excited to partner with Voxel and uLab, uniting our shared commitment to enhance patient care through disruptive solutions. Together, we are advancing the frontier of digital dentistry, empowering doctors with elegant solutions and the ability to create lasting value for their business and patients. This collaboration underscores our collective vision to shape a brighter, more connected future." uLab's uDesign software has been the established leader in digital aligner treatment planning platforms since its commercial launch in 2019. Since then, the company has been focused on creating flexible workflows to empower orthodontists, giving them greater control over their treatment plans and aligner manufacturing. uLab recently enabled direct print capabilities for the uDesign software application and is working with LuxCreo on integrations that will save time for users. Register for an upcoming event to learn more: Hands-On with 3D Printed Aligners: From Treatment Planning to Finished Aligner 1/31/25 | 2/28/25 | 3/21/25 LuxCreo, Inc., Headquarters – Chicago, IL Register Now! https://voxeldental.com/products/luxdemo Digital Workflows for In-office Printing with uLab 3/7/25 Voxel Dental Headquarters – Houston, TX Register Now! https://ulabsystems.swoogo.com/ulabvoxel About uLab Systems uLab's mission is to advance the orthodontic industry with aligner products and digital treatment planning software that let orthodontists take back control of their treatment plans to provide the best outcomes for their patients. uLab sustainably manufactures uSmile aligners in Memphis, Tennessee , recycling over 80% of manufacturing mold materials. uSmile clear aligners, the uAssist concierge service, and the uDesign software are available to orthodontic practices in the USA . To learn more, visit www.ulabsystems.com. Contact: Johanna Beckmen , pr@ulabsystems.com . About Voxel Dental Voxel Dental is the #1 provider of digital orthodontic workflow solutions, offering the industry's top brands along with decades of combined experience in dental technologies. The Voxel team field tests every digital technology we provide to recommend the highest quality tailored solutions for our customers across a comprehensive product line. Focusing on a high-tech, high-touch philosophy, we specialize in 3D printers, intraoral scanners, digital X-ray, laser welding, thermoforming plastics, and wire-bending robotics with an emphasis on providing unmatched education, training, and technical support. For more information, please visit our website at voxeldental.com or call us at 281.789.7270. Contact: Chris Koch , marketing@voxeldental.com . About LuxCreo, Inc. LuxCreo, Inc., is the leading platform for personalized medical and dental devices, dedicated to transforming patient care through innovation, speed, and customer success. We empower doctors to design, create, and deliver same-day treatments that enhance smiles, health, and well-being for a wider variety of patients. Our unique ecosystem supports dental and medical professionals with onsite, scalable solutions and flexible production with laboratory design and production services. LuxCreo helps doctors grow their practices and improve patient care by delivering more customized and effective treatments with convenience and precision. For more information, visit LuxCreo.com © 2024 uLab Systems, Inc. All Rights Reserved. uSmile and Reva are trademarks and uLab, uLab Systems, uAssist and uDesign are registered trademarks of uLab Systems, Inc. MAR-0001792 Rev 1 View original content to download multimedia: https://www.prnewswire.com/news-releases/ulab-announces-strategic-collaboration-with-voxel-and-luxcreo-to-revolutionize-direct-print-aligner-technology-302330747.html SOURCE uLab Systems, Inc.Wild first season in expanded Big 12 comes down to final weekend

Toyota’s next EV is this small Urban Cruiser SUV for Europe

Related hot word search:

Previous: gambar slotvip
Next: giri slotvip